Our annual Quality Management System audit took place at 12.05.2021. Thank you to all participants for a successful audit. General Manager: Markus Gemein
About Axel kurz
This author has not written his bio yet.
But we are proud to say that Axel kurz contributed 9 entries already.
Entries by Axel kurz
To support our customers, we initiated a new category group for your COVID-19/SARS-CoV-2 research. For details, follow the link
Now avaiable: Glucose-6-Phosphate Dehydrogenase, High-Activity, Suspension Chromatographically purified for higher specific activity. Same as Code: ZF except assayed using NAD. Phosphohexose isomerase, phosphogluconate dehydrogenase, adenylate kinase and creatine phosphokinase contaminant activities 0.02 %, 0.003 %, 0.002 % and 0.002 % respectively. A suspension in 3.7 M ammonium sulfate. Activity: ≥ 600 NAD units per mg […]
Applied StemCell’s (ASC) TARGATT™ technology allows site-specific, irreversible gene insertion (up to 20 kb). ASC has taken its proprietary knockin technology and integrated the system into CHO and HEK293 cells. The TARGATT™ CHO and HEK293 Master Cell Lines have displayed high integration efficiencies and medium to high levels of protein expression. These cell lines have […]
A Pre-clinical Model to Evaluate Therapeutics for Respiratory Infections The current COVID-19 pandemic has highlighted the need for a robust pre-clinical model of the respiratory tract that can allow researchers to accurately and efficiently test potential therapeutic agents against emergent infections like SARS-CoV-2. Influenza and coronaviruses like SARS-CoV-2 utilize the lung and airway cells of […]
We moved to a new facility with additional office spaces and increased storage capacity. Our new address: CellSystems® GmbH Junkersring 5 53844 Troisdorf Germany
Temporarily Out of Stock We are offering these two products – however, with a lower collagen concentration – as a potential option: 5153-100MG 5056-20ML
CytoSoft® T-25 and T-75 flasks provide an increased surface area for passaging cells on an in vivo-like substrate. The CytoSoft® portfolio includes a broad range of formats designed for different phases of research, including: 6-well plates – Initial discovery 24 and 96-well plates – High resolution imaging / publication quality data T-25 and T-75 flasks – Cell passaging […]
Nov 3, 2020 Düsseldorf / Germany Strengthening of the Phenion® Business Attractive portfolio with strong and successful models of the human skin Global dissemination of regulatory approved alternative test methods Important step towards the worldwide use and distribution of alternative test methods Henkel closed the acquisition of the skin model technology from the SkinInVitro GmbH, […]